Cargando…

Repurposing clinically approved cephalosporins for tuberculosis therapy

While modern cephalosporins developed for broad spectrum antibacterial activities have never been pursued for tuberculosis (TB) therapy, we identified first generation cephalosporins having clinically relevant inhibitory concentrations, both alone and in synergistic drug combinations. Common chemica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramón-García, Santiago, González del Río, Rubén, Villarejo, Angel Santos, Sweet, Gaye D., Cunningham, Fraser, Barros, David, Ballell, Lluís, Mendoza-Losana, Alfonso, Ferrer-Bazaga, Santiago, Thompson, Charles J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039641/ https://www.ncbi.nlm.nih.gov/pubmed/27678056 http://dx.doi.org/10.1038/srep34293

Ejemplares similares

Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening
por: Arenaz-Callao, María Pilar, et al.
Publicado: (2019)

Repurposing Avermectins and Milbemycins against Mycobacteroides abscessus and Other Nontuberculous Mycobacteria
por: Muñoz-Muñoz, Lara, et al.
Publicado: (2021)

Repurposing cephalosporin antibiotics as pro-senescent radiosensitizers
por: Labay, Edwardine, et al.
Publicado: (2016)

Repurposing of approved cardiovascular drugs
por: Ishida, Junichi, et al.
Publicado: (2016)

Identification and characterization of aspartyl-tRNA synthetase inhibitors against Mycobacterium tuberculosis by an integrated whole-cell target-based approach
por: Soto, Ramón, et al.
Publicado: (2018)

Repurposing approved drugs for cancer therapy
por: Schein, Catherine H
Publicado: (2021)

Repurposing approved drugs on the pathway to novel therapies
por: Schein, Catherine H.
Publicado: (2019)

Repurposing FDA-approved drugs for anti-aging therapies
por: Snell, Terry W., et al.
Publicado: (2016)

Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML
por: James, Jenna R., et al.
Publicado: (2023)

Repurposing of FDA-approved drugs against cancer – focus on metastasis
por: Ozsvári, Béla, et al.
Publicado: (2016)

Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle
por: Huang, Yue, et al.
Publicado: (2022)

Repurposing Approved Drugs for Sarcopenia Based on Transcriptomics Data in Humans
por: Liang, Shuang, et al.
Publicado: (2023)

Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?
por: Zaidi, Asifa, et al.
Publicado: (2015)

Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study
por: Sankhe, Runali, et al.
Publicado: (2021)

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
por: Bibby, Becky A. S., et al.
Publicado: (2021)

REPURPOSING OF FDA APPROVED COMPOUNDS TO INHIBIT OSM/OSMR SIGNALING IN GLIOBLASTOMA
por: Lotfipour, Farzaneh, et al.
Publicado: (2023)

Repurposing β-Lactams for the Treatment of Mycobacterium kansasii Infections: An In Vitro Study
por: Muñoz-Muñoz, Lara, et al.
Publicado: (2023)

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
por: Kim, Kevin, et al.
Publicado: (2015)

Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review
por: Andrade, Bruno Silva, et al.
Publicado: (2020)

Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor
por: Ahsan, Tamim, et al.
Publicado: (2021)

Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae
por: Abutaleb, Nader S., et al.
Publicado: (2021)

Repurposing approved therapeutics for new indication: Addressing unmet needs in psoriasis treatment
por: Jain, Harsha, et al.
Publicado: (2021)

Drug repurposing strategy II: from approved drugs to agri-fungicide leads
por: An, Jun-Xia, et al.
Publicado: (2023)

Repurposing the PDMA-approved drugs in Japan using an insect model of staphylococcal infection
por: Miyashita, Atsushi, et al.
Publicado: (2022)

Impact of Nutrition or FDA-Approved Medicine Repurposing on Metabolic Syndrome and Diabetic Complications
por: Cai, Lu
Publicado: (2023)

Etymologia: Cephalosporin
Publicado: (2005)

Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor
por: Martínez-Hoyos, María, et al.
Publicado: (2016)

Does Cephalosporin Skin Test Predict Immediate Hypersensitivity to Cephalosporin?
por: Choi, Jeong-Hee
Publicado: (2019)

Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1
por: Richter, Adrian, et al.
Publicado: (2018)

A computational drug repurposing approach in identifying the cephalosporin antibiotic and anti-hepatitis C drug derivatives for COVID-19 treatment
por: Kumar, Raj, et al.
Publicado: (2021)

Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection
por: Veljkovic, Veljko, et al.
Publicado: (2015)

Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection
por: Benedict, Ashwini, et al.
Publicado: (2015)

Can an FDA-Approved Alzheimer’s Drug Be Repurposed for Alleviating Neuronal Symptoms of Zika Virus?
por: Sirohi, Devika, et al.
Publicado: (2017)

Repurposing Clinically Approved Drugs for the Treatment of Bacillus cereus, a Surrogate for Bacillus anthracis
por: Amakawa, Masami, et al.
Publicado: (2020)

Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
por: Kandeel, Mahmoud, et al.
Publicado: (2020)

Accelerating the repurposing of FDA-approved drugs against coronavirus disease-19 (COVID-19)
por: De Vita, Simona, et al.
Publicado: (2020)

Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus
por: Mahey, Nisha, et al.
Publicado: (2021)

Drug repurposing strategy part 1: from approved drugs to agri-bactericides leads
por: Ma, Yue, et al.
Publicado: (2022)

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
por: Jones, Dylan, et al.
Publicado: (2022)

Cephalosporin-resistant typhoid
por: Pereira, Noella Maria Delia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r79sgirn3e5g750ohv00buvnqg